Uncategorized

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – July 05, 2023

KalVista Pharmaceuticals, Inc., announced that the compensation committee of KalVista’s board of directors granted two newly-hired employees inducement options to purchase an aggregate of 13,000 shares of KalVista common stock on July 3, 2023 as inducements material to each employee entering into employment with KalVista.

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – July 05, 2023 Read More »

Just – Evotec Biologics Awarded Second Contract from U.S. Department of Defense Under Accelerated Antibodies Program

Evotec SE announced that the U.S. Department of Defense has awarded Evotec’s Seattle-based subsidiary, Just – Evotec Biologics, Inc. a contract valued up to $ 74 m for the rapid development of monoclonal antibody -based drug product prototypes targeting orthopoxviruses.

Just – Evotec Biologics Awarded Second Contract from U.S. Department of Defense Under Accelerated Antibodies Program Read More »

Scroll to Top